The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $108.14

Today's change+1.60 +1.50%
Updated May 25 4:02 PM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $108.14

Today's change+1.60 +1.50%
Updated May 25 4:02 PM EDT. Delayed by at least 15 minutes.

Quest Diagnostics Inc Hits New 52-week High

Quest Diagnostics Inc closed up sharply Thursday, rallying (U.S.)$1.60 or 1.50% to (U.S.)$108.14 and setting a new 52-week high. Over the last five days, shares have gained 2.36% and 17.67% year to date. Shares have outperformed the S&P 500 by 24.25% during the last year.

Key company metrics

  • Open(U.S.) $106.75
  • Previous close(U.S.) $106.54
  • High(U.S.) $108.52
  • Low(U.S.) $106.50
  • Bid / Ask-- / --
  • YTD % change+17.67%
  • Volume678,563
  • Average volume (10-day)829,061
  • Average volume (1-month)1,038,104
  • Average volume (3-month)902,048
  • 52-week range(U.S.) $75.20 to (U.S.) $108.52
  • Beta0.71
  • Trailing P/E21.64×
  • P/E 1 year forward19.46×
  • Forward PEG2.38×
  • Indicated annual dividend(U.S.) $1.80
  • Dividend yield1.66%
  • Trailing EPS(U.S.) $5.00
Updated May 25 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.06%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue1,8991,8611,8851,906
Total other revenue--------
Total revenue1,8991,8611,8851,906
Gross profit736760729753
Total cost of revenue1,1631,1011,1561,153
Total operating expense1,6201,5851,5631,484
Selling / general / administrative436363407429
Research & development--------
Depreciation / amortization17181817
Interest expense (income), net operating--------
Unusual expense (income)3963-115
Other operating expenses, total17-210
Operating income279276322422
Interest income (expense), net non-operating-37-36-37-35
Gain (loss) on sale of assets--------
Other--------
Income before tax253251300392
Income after tax175167205209
Income tax, total788495183
Net income164155192195
Total adjustments to net income--0-2-1
Net income before extra. items164155192195
Minority interest-11-12-13-14
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items164155190194
Inc. avail. to common incl. extra. items164155190194
Diluted net income164155192194
Dilution adjustment----2--
Diluted weighted average shares141139142142
Diluted EPS excluding extraordinary itemsvalue per share1.161.121.351.37
Dividends per sharevalue per share0.450.400.400.40
Diluted normalized EPSvalue per share1.181.571.370.93